What is the ticker symbol for Indaptus Therapeutics?

Indaptus Therapeutics trades under the ticker INDP on NASDAQ.

What sector does Indaptus Therapeutics operate in?

Indaptus Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze INDP in a portfolio?

PortView shows INDP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Indaptus Therapeutics (INDP) Stock Analysis

NASDAQHealthcareBiotechnology

$1.15+1.77%

1-year price historyRange $0.94 – $5.40

52-week range$1.15

$0.92$8.57

What Indaptus Therapeutics does

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.

Key metrics

Market cap

$130.23M

P/E (TTM)

-0.07

EPS (TTM)

$-15.40

Beta

1.18

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.98

200-day avg

$2.21

52-week high

$8.57

52-week low

$0.92

CEO

Junyi Dai

ETFs linked to INDP

Broad-market and Healthcare sector ETFs an investor holding Indaptus Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how INDP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INDP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Indaptus Therapeutics?: Indaptus Therapeutics trades under the ticker INDP on NASDAQ.
Which exchange is INDP listed on?: INDP is listed on NASDAQ.
What sector does Indaptus Therapeutics operate in?: Indaptus Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INDP in a portfolio?: PortView shows INDP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.